Theraclion SA (TCLIF)

0.5900 0.0000 (0.00%) At close: 02:14PM EDT

Theraclion SA

102 Rue Etienne Dolet
Malakoff 92240
France
33 1 55 48 90 70
https://www.theraclion.com

Sector(s): Healthcare
Industry: Medical Devices
Full Time Employees: 

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Yann M. Duchesne	Executive Chairman	505.86k	N/A	1956
Mr. Martin Deterre	Chief Executive Officer	N/A	N/A	N/A
Ms. Laurence Gericot	Administrative & Financial Director	N/A	N/A	1965
Gaylord Tallec	Vice President of Operations	N/A	N/A	N/A
Jérémie Anquez	VP Research & Chief Scientific Officer	N/A	N/A	N/A
Mr. Jose Abellan-Martinez	Vice President of Sales & Business Development	N/A	N/A	N/A
Marie Berne	Marketing & Customer Relations Director	N/A	N/A	N/A
Mr. Michel Nuta M.D.	VP of Veins & Chief Medical Officer	N/A	N/A	N/A

Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Theraclion SA develops echotherapy solutions using high intensity focused ultrasound system. It offers SONOVEIN, a robotic solution for non-invasive echotherapy treatment of varicose veins; ECHOPULSE, a robotic and non-invasive solution for echotherapy treatment of thyroid nodules and breast fibroadenoma; and EPack, a disposable that is installed on the device before treatment and protects the patient's skin and optimizes the image quality. Theraclion SA was founded in 2004 and is based in Malakoff, France.

Corporate Governance

Theraclion SA’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.